Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Retained Earnings: 2023-2024

Historic Retained Earnings for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$190.8 million.

  • Upstream Bio's Retained Earnings fell 72.11% to -$291.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$291.8 million, marking a year-over-year decrease of 72.11%. This contributed to the annual value of -$190.8 million for FY2024, which is 49.08% down from last year.
  • Latest data reveals that Upstream Bio reported Retained Earnings of -$190.8 million as of FY2024, which was down 49.08% from -$128.0 million recorded in FY2023.
  • Upstream Bio's 5-year Retained Earnings high stood at -$128.0 million for FY2023, and its period low was -$190.8 million during FY2024.
  • Over the past 2 years, Upstream Bio's median Retained Earnings value was -$159.4 million (recorded in 2023), while the average stood at -$159.4 million.
  • Data for Upstream Bio's Retained Earnings shows a maximum YoY crashed of 49.08% (in 2024) over the last 5 years.
  • Upstream Bio's Retained Earnings (Yearly) stood at -$128.0 million in 2023, then plummeted by 49.08% to -$190.8 million in 2024.